Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19

Author(s): Cindy Bandala

Volume 22, Issue 16, 2022

Published on: 07 July, 2022

Page: [1306 - 1306] Pages: 1

DOI: 10.2174/156802662216220707104738

« Previous Next »
Graphical Abstract

[1]
Hernández-Ochoa B, Ortega-Cuellar D, González-Valdez A, Cárdenas-Rodríguez N, Mendoza-Torreblanca JG, Contreras-García IJ, et al. COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology. Curr Top Med Chem., 2022, 22(16), 1307-1325. Available from:
[http://dx.doi.org/10.2174/1568026622666220516111122]
[2]
Sixto-López Y, Correa-Basurto J. HDAC inhibition as neuroprotection in COVID-19 infection. Curr Top Med Chem., 2022, 22(16), 1369-1378. Available from:
[http://dx.doi.org/10.2174/1568026622666220303113445]
[3]
Cortes-Altamirano JL, Yáñes-Pizaña A, Reyes-Long S, Angélica G-M, Bandala C, Bonilla-Jaime H, et al. Potential neuroprotective effect of cannabinoids in covid-19 patients. Curr Top Med Chem., 2022, 22(16), 1326-1345. Available from:
[http://dx.doi.org/10.2174/1568026622666220405143003]
[4]
Quintero-Fabián S, Bandala C, Pichardo-Macías LA, Contreras-García IJ, Gómez-Manzo S, Hernández-Ochoa B, et al. Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature. Curr Top Med Chem., 2022, 22(16), 1346-1368. Available from:
[http://dx.doi.org/10.2174/1568026622666220401140737]

Rights & Permissions Print Cite
Article Metrics
11
1
© 2024 Bentham Science Publishers | Privacy Policy